Galecto (GLTO) CMO reports no beneficial ownership in SEC Form 3 filing

Rhea-AI Filing Summary

Galecto, Inc.’s Chief Medical Officer files an initial ownership report showing no holdings. Hewes L. Becker, the company’s Chief Medical Officer, submitted a Form 3 indicating that no securities of Galecto, Inc. are beneficially owned. The filing confirms his officer role and that this is an individual filing, with a remark explicitly stating that no securities are beneficially owned.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hewes L. Becker

(Last) (First) (Middle)

C/O GALECTO, INC.,

221 CRESCENT ST, BUILDING 23, SUITE 105

(Street)

WALTHAM MA 02453

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/05/2026

3. Issuer Name and Ticker or Trading Symbol
Galecto, Inc. [ GLTO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Lori Firmani, attorney-in-fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Galecto (GLTO) disclose in this Form 3 filing?

The filing discloses that Chief Medical Officer Hewes L. Becker currently has no securities beneficially owned in Galecto, Inc.

Who is the reporting person in Galecto (GLTO)’s latest Form 3?

The reporting person is Hewes L. Becker, who serves as Chief Medical Officer of Galecto, Inc.

Are any Galecto (GLTO) shares or derivatives reported as owned in this Form 3?

No. The remarks section states that no securities are beneficially owned, and the transaction tables show no holdings.

Does the Galecto (GLTO) Form 3 show any insider transactions?

No. The Form 3 lists no transactions and confirms that there are currently no securities beneficially owned by the reporting person.

What is the relationship of the reporting person to Galecto (GLTO)?

Hewes L. Becker is identified as an officer of Galecto, Inc., specifically the Chief Medical Officer, and is not a 10% owner.

What is the event date for this Galecto (GLTO) Form 3?

The Form 3 lists the date of event requiring statement as 01/05/2026.